(Q37628691)

21 August 2017

1 reference

title

Key signaling molecules in pituitary tumors (English)

1 reference

21 August 2017

author name string

Cristiana Pistol Tanase

series ordinal

1

1 reference

21 August 2017

Monica Neagu

series ordinal

2

1 reference

21 August 2017

Radu Albulescu

series ordinal

3

1 reference

21 August 2017

publication date

1 November 2009

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

859-877

1 reference

Molecular targets in pituitary tumours

21 August 2017

cites work

1 reference

Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations

21 January 2018

1 reference

Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis

21 January 2018

1 reference

Classification and pathology of pituitary tumors

21 January 2018

1 reference

Predictive markers of pituitary adenoma behavior

21 January 2018

1 reference

Pathobiology of pituitary adenomas and carcinomas.

21 January 2018

1 reference

The 2004 World Health Organization classification of pituitary tumors: what is new?

21 January 2018

1 reference

Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior

21 January 2018

1 reference

Epidermal growth factor receptor pathway substrate 8 is overexpressed in human pituitary tumors: role in proliferation and survival

21 January 2018

1 reference

The molecular biology of pituitary tumors: a personal perspective

21 January 2018

1 reference

Cell cycle control of pituitary development and disease

21 January 2018

1 reference

Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update.

21 January 2018

1 reference

Heregulin regulates prolactinoma gene expression

21 January 2018

1 reference

Hormonal signaling and pituitary adenomas.

21 January 2018

1 reference

Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK).

21 January 2018

1 reference

Pituitary tumor-transforming gene: physiology and implications for tumorigenesis

21 January 2018

1 reference

Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation

21 January 2018

1 reference

Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression

21 January 2018

1 reference

Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.

21 January 2018

1 reference

The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology

21 January 2018

1 reference

Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor

21 January 2018

1 reference

Activation of mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent

21 January 2018

1 reference

Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways

21 January 2018

1 reference

Gonadotropin-releasing hormone in apoptosis of prostate cancer cells

21 January 2018

1 reference

Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor

21 January 2018

1 reference

Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation.

21 January 2018

1 reference

SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2.

21 January 2018

1 reference

Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas

21 January 2018

1 reference

Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

21 January 2018

1 reference

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

21 January 2018

1 reference

Retinoic acid prevents experimental Cushing syndrome

21 January 2018

1 reference

Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues

21 January 2018

1 reference

Differential role of progesterone receptor isoforms in the transcriptional regulation of human gonadotropin-releasing hormone I (GnRH I) receptor, GnRH I, and GnRH II

21 January 2018

1 reference

Levonorgestrel antagonism on estrogen-induced pituitary tumors is mediated by progesterone receptors

21 January 2018

1 reference

The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas

21 January 2018

1 reference

Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis

21 January 2018

1 reference

Securin is required for chromosomal stability in human cells

21 January 2018

1 reference

Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function

21 January 2018

1 reference

Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase

21 January 2018

1 reference

Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes

21 January 2018

1 reference

Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis

21 January 2018

1 reference

PTTG/securin activates expression of p53 and modulates its function

21 January 2018

1 reference

Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth

21 January 2018

1 reference

Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors

21 January 2018

1 reference

PTTG overexpression is correlated with angiogenesis in human pituitary adenomas.

21 January 2018

1 reference

Pituitary tumor transforming gene overexpression facilitates pituitary tumor development.

21 January 2018

1 reference

Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis

21 January 2018

1 reference

Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.

21 January 2018

1 reference

Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.

21 January 2018

1 reference

Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas.

21 January 2018

1 reference

Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells.

21 January 2018

1 reference

Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy

21 January 2018

1 reference

Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment

21 January 2018

1 reference

Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.

21 January 2018

1 reference

Fibroblast growth factors regulate prolactin transcription via an atypical Rac-dependent signaling pathway

21 January 2018

1 reference

Akting and cycling: a tale of the pituitary

21 January 2018

1 reference

Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors

21 January 2018

1 reference

Drug discovery approaches targeting the PI3K/Akt pathway in cancer

21 January 2018

1 reference

Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors

21 January 2018

1 reference

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

Signaling and epigenetic regulation of pituitary development

21 January 2018

1 reference

Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway

21 January 2018

1 reference

Wnt pathway inhibitors are strongly down-regulated in pituitary tumors

21 January 2018

1 reference

Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades

21 January 2018

1 reference

The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.

21 January 2018

1 reference

Mammalian cyclin-dependent kinases

21 January 2018

1 reference

Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.

21 January 2018

1 reference

Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas.

21 January 2018

1 reference

The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications

21 January 2018

1 reference

CDK inhibitors in cancer therapy: what is next?

21 January 2018

1 reference

A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy

21 January 2018

1 reference

Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity

21 January 2018

1 reference

Pathology of the human pituitary adenomas

21 January 2018

1 reference

Pituitary adenoma predisposition caused by germline mutations in the AIP gene.

21 January 2018

1 reference

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

21 January 2018

1 reference

Somatic mutations of the mitochondrial genome in human colorectal tumours

21 January 2018

1 reference

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas

21 January 2018

1 reference

Regulation of human separase by securin binding and autocleavage

21 January 2018

1 reference

Expression of p53, Ki-67 and c-erb B2 in growth hormone-and/or prolactin-secreting pituitary adenomas.

21 January 2018

1 reference

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

21 January 2018

1 reference

Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4

21 January 2018

1 reference

A Growth Hormone Receptor Mutation Impairs Growth Hormone Autofeedback Signaling in Pituitary Tumors

21 January 2018

1 reference

Aryl hydrocarbon receptor interacting protein(AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.09.60

1 reference

21 August 2017

1 reference